Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 184

    1.

    Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy.

    Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, Zambanini A, O'Brien E, Chaturvedi N, Lyons S, Byrd S, Poulter NR, Sever PS, Mayet J; on behalf of the ASCOT Investigators.

    Eur Heart J. 2009 Nov 26. [Epub ahead of print]PMID: 19942604 [PubMed - as supplied by publisher]

    2.

    Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial.

    Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A, Badruddin SH, Chaturvedi N; Hypertension Research Group.

    Ann Intern Med. 2009 Nov 3;151(9):593-601.PMID: 19884620 [PubMed - in process]Related articles

    3.

    Initiation of programmed cell death in self-incompatibility: role for cytoskeleton modifications and several caspase-like activities.

    Bosch M, Poulter NS, Vatovec S, Franklin-Tong VE.

    Mol Plant. 2008 Nov;1(6):879-87. Epub 2008 Oct 17.PMID: 19825589 [PubMed - in process]Related articles

    4.

    Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).

    Poulter NR, Dobson JE, Sever PS, Dahlöf B, Wedel H, Campbell NR; ASCOT Investigators.

    J Am Coll Cardiol. 2009 Sep 22;54(13):1154-61.PMID: 19761936 [PubMed - indexed for MEDLINE]Related articles

    5.

    Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT).

    Manisty C, Mayet J, Tapp RJ, Sever PS, Poulter N, McG Thom SA, Hughes AD; ASCOT Investigators.

    Hypertension. 2009 Nov;54(5):1009-13. Epub 2009 Aug 31.PMID: 19720956 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

    de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, Macmahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M; for the ADVANCE Collaborative group.

    Diabetologia. 2009 Nov;52(11):2328-2336. Epub 2009 Aug 18.PMID: 19688336 [PubMed - as supplied by publisher]Related articles

    7.

    Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.

    Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, MacMahon S, Marre M, Neal B, Patel A, Woodward M, Chalmers J; ADVANCE Collaborative Group, Cass A, Glasziou P, Harrap S, Lisheng L, Mancia G, Pillai A, Poulter N, Perkovic V, Travert F.

    Diabetes Care. 2009 Nov;32(11):2068-74. Epub 2009 Aug 3.PMID: 19651921 [PubMed - in process]Related articles

    8.

    Hypertension and its identification among current, past and never smokers in an English population sample.

    Shahab L, Mindell J, Poulter NR, West R.

    Eur J Cardiovasc Prev Rehabil. 2009 Jul 15. [Epub ahead of print]PMID: 19609210 [PubMed - as supplied by publisher]Related articles

    9.

    Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.

    Thom S, Stettler C, Stanton A, Witt N, Tapp R, Chaturvedi N, Allemann S, Mayet J, Sever P, Poulter N, O'Brien E, Hughes A.

    Hypertension. 2009 Aug;54(2):405-8. Epub 2009 Jun 15.PMID: 19528363 [PubMed - indexed for MEDLINE]Related articles

    10.

    Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.

    Poulter NR.

    J Hypertens. 2009 May;27 Suppl 1:S3-8.PMID: 19483505 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of HIV status and antiretroviral therapy on blood pressure.

    Wilson SL, Scullard G, Fidler SJ, Weber JN, Poulter NR.

    HIV Med. 2009 Jul;10(6):388-94. Epub 2009 Mar 26.PMID: 19490176 [PubMed - in process]Related articles

    12.

    Identification of the pollen self-incompatibility determinant in Papaver rhoeas.

    Wheeler MJ, de Graaf BH, Hadjiosif N, Perry RM, Poulter NS, Osman K, Vatovec S, Harper A, Franklin FC, Franklin-Tong VE.

    Nature. 2009 Jun 18;459(7249):992-5. Epub 2009 May 31.PMID: 19483678 [PubMed - indexed for MEDLINE]Related articles

    13.

    Blood pressure variables and cardiovascular risk: new findings from ADVANCE.

    Kengne AP, Czernichow S, Huxley R, Grobbee D, Woodward M, Neal B, Zoungas S, Cooper M, Glasziou P, Hamet P, Harrap SB, Mancia G, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative Group.

    Hypertension. 2009 Aug;54(2):399-404. Epub 2009 May 26.PMID: 19470869 [PubMed - indexed for MEDLINE]Related articles

    14.

    Implementation of pay for performance policy in England.

    Falaschetti E, Campbell NR, Mohan S, Poulter N.

    Hypertension. 2009 Jul;54(1):e5. Epub 2009 May 26. No abstract available. PMID: 19470868 [PubMed - indexed for MEDLINE]Related articles

    15.

    Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

    Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group.

    J Am Soc Nephrol. 2009 Aug;20(8):1813-21. Epub 2009 May 14.PMID: 19443635 [PubMed - indexed for MEDLINE]Related articles

    16.

    The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.

    Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT investigators.

    Pharmacoeconomics. 2009;27(3):221-30. doi: 10.2165/00019053-200927030-00005.PMID: 19354342 [PubMed - indexed for MEDLINE]Related articles

    17.

    Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies.

    White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, Haysom L, Craig JC, Salmi IA, Chadban SJ, Huxley RR.

    Am J Kidney Dis. 2009 Aug;54(2):248-61. Epub 2009 Apr 1. Review.PMID: 19339091 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.

    Sever PS, Poulter NR, Dahlof B, Wedel H; ASCOT Investigators.

    J Hypertens. 2009 May;27(5):947-54.PMID: 19318984 [PubMed - indexed for MEDLINE]Related articles

    19.

    Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.

    Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GY, Patel A; ADVANCE Collaborative Group.

    Eur Heart J. 2009 May;30(9):1128-35. Epub 2009 Mar 11.PMID: 19282274 [PubMed - indexed for MEDLINE]Related articles

    20.

    Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudy.

    Stettler C, Witt N, Tapp RJ, Thom S, Allemann S, Tillin T, Stanton A, O'Brien E, Poulter N, Gallimore JR, Hughes AD, Chaturvedi N.

    Diabetes Care. 2009 Jun;32(6):1098-100. Epub 2009 Feb 24.PMID: 19244088 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Coronary heart disease benefits from blood pressure and lipid-lowering.

    Sever PS, Poulter NR, Mastorantonakis S, Chang CL, Dahlof B, Wedel H; ASCOT Investigators.

    Int J Cardiol. 2009 Jun 26;135(2):218-22. Epub 2009 Feb 20.PMID: 19232755 [PubMed - indexed for MEDLINE]Related articles

    22.

    Lowering blood pressure reduces renal events in type 2 diabetes.

    de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group.

    J Am Soc Nephrol. 2009 Apr;20(4):883-92. Epub 2009 Feb 18.PMID: 19225038 [PubMed - indexed for MEDLINE]Related articles

    23.

    Continued improvement in hypertension management in England: results from the Health Survey for England 2006.

    Falaschetti E, Chaudhury M, Mindell J, Poulter N.

    Hypertension. 2009 Mar;53(3):480-6. Epub 2009 Feb 9.PMID: 19204180 [PubMed - indexed for MEDLINE]Related articles

    24.

    The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.

    Ostergren J, Poulter NR, Sever PS, Dahlöf B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E; ASCOT investigators.

    J Hypertens. 2008 Nov;26(11):2103-11.PMID: 18854748 [PubMed - indexed for MEDLINE]Related articles

    25.

    Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.

    Sharp A, Tapp R, Francis DP, McG Thom SA, Hughes AD, Stanton AV, Zambanini A, Chaturvedi N, Byrd S, Poulter NR, Sever PS, Mayet J.

    J Am Coll Cardiol. 2008 Sep 16;52(12):1015-21.PMID: 18786484 [PubMed - indexed for MEDLINE]Related articles

    26.

    Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.

    Chapman N, Chang CL, Dahlöf B, Sever PS, Wedel H, Poulter NR; ASCOT Investigators.

    Circulation. 2008 Jul 1;118(1):42-8. Epub 2008 Jun 16.PMID: 18559700 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

    ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

    N Engl J Med. 2008 Jun 12;358(24):2560-72. Epub 2008 Jun 6.PMID: 18539916 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.

    Gupta AK, Dahlof B, Dobson J, Sever PS, Wedel H, Poulter NR; Anglo-Scandinavian Cardiac Outcomes Trial Investigators.

    Diabetes Care. 2008 May;31(5):982-8. Epub 2008 Jan 30.PMID: 18235048 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Microtubules are a target for self-incompatibility signaling in Papaver pollen.

    Poulter NS, Vatovec S, Franklin-Tong VE.

    Plant Physiol. 2008 Mar;146(3):1358-67. Epub 2008 Jan 11.PMID: 18192439 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

    Sever PS, Poulter NR, Dahlof B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes G, Mehlsen J, Nieminen MS, O'Brien ET, Ostergren J; ASCOT Investigators.

    Eur Heart J. 2008 Feb;29(4):499-508. Epub 2008 Jan 5.PMID: 18175773 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.

    Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT trial investigators.

    Heart. 2008 Feb;94(2):e4. Epub 2007 Oct 4.PMID: 17916665 [PubMed - indexed for MEDLINE]Related articles

    32.

    Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

    Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

    Lancet. 2007 Sep 8;370(9590):829-40.PMID: 17765963 [PubMed - indexed for MEDLINE]Related articles

    33.

    Antihypertensive-associated incident diabetes: controversy persists.

    Gupta AK, Poulter NR.

    Arch Intern Med. 2007 Jul 9;167(13):1433; author reply 1434-5. No abstract available. PMID: 17620540 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effect of spironolactone on blood pressure in subjects with resistant hypertension.

    Chapman N, Dobson J, Wilson S, Dahlöf B, Sever PS, Wedel H, Poulter NR; Anglo-Scandinavian Cardiac Outcomes Trial Investigators.

    Hypertension. 2007 Apr;49(4):839-45. Epub 2007 Feb 19.PMID: 17309946 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy.

    Lindgren P, Kahan T, Poulter N, Buxton M, Svarvar P, Dahlöf B, Jonsson B; ASCOT investigators.

    Eur J Health Econ. 2007 Mar;8(1):25-30.PMID: 17165074 [PubMed - indexed for MEDLINE]Related articles

    36.

    Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.

    Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O'Brien E, Ostergren J; ASCOT Steering Committee Members.

    Eur Heart J. 2006 Dec;27(24):2982-8. Epub 2006 Dec 4. Erratum in: Eur Heart J. 2007 Jan;28(1):142. PMID: 17145722 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005.

    Poulter N, Hughes AD, Williams B, Brady AJ, McInnes G; British Hypertension Society.

    J Renin Angiotensin Aldosterone Syst. 2006 Jun;7(2):104-21. No abstract available. PMID: 17083065 [PubMed - indexed for MEDLINE]Related articles

    38.

    The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults.

    Wilson SL, Poulter NR.

    J Hypertens. 2006 Aug;24(8):1457-69. Review.PMID: 16877945 [PubMed - indexed for MEDLINE]Related articles

    39.

    ESH-ESC guidelines for the management of hypertension.

    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.

    Herz. 2006 Jun;31(4):331-8.PMID: 16810473 [PubMed - indexed for MEDLINE]Related articles

    40.

    Blood pressure reduction is not the only determinant of outcome.

    Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR.

    Circulation. 2006 Jun 13;113(23):2754-72; discussion 2773-4. No abstract available. PMID: 16769926 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Improvement in hypertension management in England: results from the Health Survey for England 2003.

    Primatesta P, Poulter NR.

    J Hypertens. 2006 Jun;24(6):1187-92.PMID: 16685220 [PubMed - indexed for MEDLINE]Related articles

    42.

    Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003.

    Primatesta P, Poulter NR.

    Clin Endocrinol (Oxf). 2006 Mar;64(3):292-8.PMID: 16487439 [PubMed - indexed for MEDLINE]Related articles

    43.

    Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

    Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, Pocock S; ASCOT Investigators.

    Lancet. 2005 Sep 10-16;366(9489):907-13.PMID: 16154017 [PubMed - indexed for MEDLINE]Related articles

    44.

    Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

    Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators.

    Lancet. 2005 Sep 10-16;366(9489):895-906.PMID: 16154016 [PubMed - indexed for MEDLINE]Related articles

    45.

    Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.

    Ruilope LM, Rosei EA, Bakris GL, Mancia G, Poulter NR, Taddei S, Unger T, Volpe M, Waeber B, Zannad F.

    Blood Press. 2005;14(4):196-209. Review.PMID: 16126553 [PubMed - indexed for MEDLINE]Related articles

    46.

    Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).

    Sever PS, Poulter NR, Dahlöf B, Wedel H; Anglo-Scandinavian Cardiac Outcomes Trial Investigators.

    Am J Cardiol. 2005 Sep 5;96(5A):39F-44F. Review.PMID: 16126022 [PubMed - indexed for MEDLINE]Related articles

    47.

    ADVANCE: action in diabetes and vascular disease.

    Patel A, Chalmers J, Poulter N.

    J Hum Hypertens. 2005 Jun;19 Suppl 1:S27-32. Review.PMID: 16075030 [PubMed - indexed for MEDLINE]Related articles

    48.

    Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

    Sever PS, Poulter NR, Dahlöf B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J.

    Diabetes Care. 2005 May;28(5):1151-7.PMID: 15855581 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Children in South Asia have higher body mass-adjusted blood pressure levels than white children in the United States: a comparative study.

    Jafar TH, Islam M, Poulter N, Hatcher J, Schmid CH, Levey AS, Chaturvedi N.

    Circulation. 2005 Mar 15;111(10):1291-7.PMID: 15769771 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

    Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators.

    Drugs. 2004;64 Suppl 2:43-60.PMID: 15765890 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...